These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21512508)

  • 1. Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model.
    Tabata K; Kurosaka S; Watanabe M; Edamura K; Satoh T; Yang G; Abdelfattah E; Wang J; Goltsov A; Floryk D; Thompson TC
    Gene Ther; 2011 Oct; 18(10):969-78. PubMed ID: 21512508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer model.
    Satoh T; Saika T; Ebara S; Kusaka N; Timme TL; Yang G; Wang J; Mouraviev V; Cao G; Fattah el MA; Thompson TC
    Cancer Res; 2003 Nov; 63(22):7853-60. PubMed ID: 14633713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma pathogenesis-related protein 1: tumor-suppressor activities and therapeutic potential.
    Thompson TC
    Yonsei Med J; 2010 Jul; 51(4):479-83. PubMed ID: 20499410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model.
    Saika T; Satoh T; Kusaka N; Ebara S; Mouraviev VB; Timme TL; Thompson TC
    Cancer Gene Ther; 2004 May; 11(5):317-24. PubMed ID: 15044961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer models.
    Fujita T; Satoh T; Timme TL; Hirayama T; Zhu JX; Kusaka N; Naruishi K; Yang G; Goltsov A; Wang J; Vlachaki MT; Teh BS; Brian Butler E; Thompson TC
    Urol Oncol; 2014 Feb; 32(2):92-100. PubMed ID: 23433894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer.
    Satoh T; Timme TL; Saika T; Ebara S; Yang G; Wang J; Ren C; Kusaka N; Mouraviev V; Thompson TC
    Hum Gene Ther; 2003 Jan; 14(2):91-101. PubMed ID: 12614561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer.
    Tabata K; Watanabe M; Naruishi K; Edamura K; Satoh T; Yang G; Abdel Fattah E; Wang J; Goltsov A; Floryk D; Soni SD; Kadmon D; Thompson TC
    Prostate Cancer Prostatic Dis; 2009; 12(3):301-9. PubMed ID: 19104507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy.
    Sonpavde G; Thompson TC; Jain RK; Ayala GE; Kurosaka S; Edamura K; Tabata K; Ren C; Goltsov AA; Mims MP; Hayes TG; Ittmann MM; Wheeler TM; Gee A; Miles BJ; Kadmon D
    Clin Cancer Res; 2011 Nov; 17(22):7174-82. PubMed ID: 21933889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of oncolytic adenovirus expressing suicide genes and interleukin-12 in preclinical model of prostate cancer.
    Freytag SO; Barton KN; Zhang Y
    Gene Ther; 2013 Dec; 20(12):1131-9. PubMed ID: 23842593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.
    Nasu Y; Bangma CH; Hull GW; Lee HM; Hu J; Wang J; McCurdy MA; Shimura S; Yang G; Timme TL; Thompson TC
    Gene Ther; 1999 Mar; 6(3):338-49. PubMed ID: 10435084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell based PSMA immunotherapy for prostate cancer using a CD40-targeted adenovirus vector.
    Williams BJ; Bhatia S; Adams LK; Boling S; Carroll JL; Li XL; Rogers DL; Korokhov N; Kovesdi I; Pereboev AV; Curiel DT; Mathis JM
    PLoS One; 2012; 7(10):e46981. PubMed ID: 23056548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.
    Eastham JA; Grafton W; Martin CM; Williams BJ
    J Urol; 2000 Sep; 164(3 Pt 1):814-9. PubMed ID: 10953161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.
    Fujita T; Timme TL; Tabata K; Naruishi K; Kusaka N; Watanabe M; Abdelfattah E; Zhu JX; Ren C; Ren C; Yang G; Goltsov A; Wang H; Vlachaki MT; Teh BS; Butler EB; Thompson TC
    Gene Ther; 2007 Feb; 14(3):227-36. PubMed ID: 17024109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model.
    Saika T; Kusaka N; Mouraviev V; Satoh T; Kumon H; Timme TL; Thompson TC
    Cancer Gene Ther; 2006 Jan; 13(1):91-8. PubMed ID: 16052232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent contributions of GR-1+ leukocytes and Fas/FasL interactions to induce apoptosis following interleukin-12 gene therapy in a metastatic model of prostate cancer.
    Sanford MA; Yan Y; Canfield SE; Hassan W; Selleck WA; Atkinson G; Chen SH; Hall SJ
    Hum Gene Ther; 2001 Aug; 12(12):1485-98. PubMed ID: 11506692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation improves intratumoral gene therapy for induction of cancer vaccine in murine prostate carcinoma.
    Hillman GG; Xu M; Wang Y; Wright JL; Lu X; Kallinteris NL; Tekyi-Mensah S; Thompson TC; Mitchell MS; Forman JD
    Hum Gene Ther; 2003 May; 14(8):763-75. PubMed ID: 12804139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer.
    Naruishi K; Timme TL; Kusaka N; Fujita T; Yang G; Goltsov A; Satoh T; Ji X; Tian W; Abdelfattah E; Men T; Watanabe M; Tabata K; Thompson TC
    Cancer Gene Ther; 2006 Jul; 13(7):658-63. PubMed ID: 16485011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice.
    Zhang F; Lu W; Dong Z
    Clin Cancer Res; 2002 Sep; 8(9):2942-51. PubMed ID: 12231540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer.
    Hall SJ; Sanford MA; Atkinson G; Chen SH
    Cancer Res; 1998 Aug; 58(15):3221-5. PubMed ID: 9699645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma pathogenesis-related protein 1 exerts tumor suppressor activities through proapoptotic reactive oxygen species-c-Jun-NH2 kinase signaling.
    Li L; Abdel Fattah E; Cao G; Ren C; Yang G; Goltsov AA; Chinault AC; Cai WW; Timme TL; Thompson TC
    Cancer Res; 2008 Jan; 68(2):434-43. PubMed ID: 18199537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.